Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This study aims to compare the response of triple-negative breast cancer with deficient homologous recombination to intensified alkylating chemotherapy versus standard chemotherapy with dose dense AC and/or Docetaxel-Capecitabine.
Epistemonikos ID: c48a16c85cb9a609b3c1b7faf703cc3be5f1e9a3
First added on: May 05, 2024